MSC Pretreatment for Improved Transplantation Viability Results in Improved Ventricular Function in Infarcted Hearts

MSC Pretreatment for Improved Transplantation Viability Results in Improved Ventricular Function in Infarcted Hearts

Many clinical studies utilizing MSCs (mesenchymal stem cells, mesenchymal stromal cells, or multipotential stromal cells) are underway in multiple clinical settings; however, the ideal approach to prepare these cells in vitro and to deliver them to injury sites in vivo with maximal effectiveness rem...

Full description

Bibliographic Details
Main Authors: Mark F. Pittenger, Saman Eghtesad, Pablo G. Sanchez, Xiaoyan Liu, Zhongjun Wu, Ling Chen, Bartley P. Griffith
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
MSC
pretreatment
prosurvival factors
myocardial infarct
improved ejection fraction
rat model
Online Access:https://www.mdpi.com/1422-0067/23/2/694

Internet

https://www.mdpi.com/1422-0067/23/2/694

Similar Items